醫藥包裝市場－全球產業規模、佔有率、趨勢、機會與預測，依材料、產品、藥物傳輸、最終用途、地區和競爭細分，2020-2030 年預測

2024年，醫藥包裝市場規模達1,531億美元，預計2030年將達2,665.4億美元，複合年成長率達9.68%。全球醫藥包裝市場正經歷快速的結構性變革，這得益於藥品生產量的激增、對法規合規性的日益重視以及藥物輸送系統的持續創新。包裝已成為醫藥價值鏈中策略性的推動因素，確保產品穩定性、病人安全和監管透明度，同時提升日益複雜的全球供應網路的物流效率。

生物製劑、特種藥物和個人化療法的需求日益成長，進一步加速了這一轉變，這些領域都需要更複雜、更客製化的包裝形式。在先進材料科學、數位化追溯解決方案以及日益嚴格的全球監管標準的支撐下，醫藥包裝市場將迎來強勁持續的成長，而這些都將重塑醫藥包裝的未來。

關鍵市場促進因素

全球藥品產量不斷成長

主要市場挑戰

嚴格且不斷變化的監管要求

雖然法規可以確保安全，但也增加了成本和複雜性，這可能會減緩創新、阻礙投資並降低製造商在全球擴展的能力。

主要市場趨勢

智慧互聯包裝解決方案的整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID 19 對醫藥包裝市場的影響

第5章：醫藥包裝市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按材料（塑膠和聚合物、紙和紙板、玻璃、鋁箔、其他）
  • 按產品（初級、次級、第三級）
  • 依藥物輸送（口服藥物、注射藥物、外用藥物、眼部藥物、鼻腔藥物、肺部藥物、經皮藥物、靜脈注射藥物、其他）
  • 依最終用途（製藥製造、合約包裝、零售藥房、機構藥房）
  • 按地區
  • 按公司分類（2024 年）
• 市場地圖

第6章：北美醫藥包裝市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲醫藥包裝市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太醫藥包裝市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲醫藥包裝市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲醫藥包裝市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第13章：全球醫藥包裝市場：SWOT分析

第 14 章：競爭格局

• Amcor plc
• Becton, Dickinson, and Company
• AptarGroup, Inc
• Drug Plastics & Glass Co., Inc
• Gerresheimer AG
• Schott AG
• OI Glass, Inc.
• West Pharmaceutical Services, Inc
• WestRock Company
• SGD Pharma

第 15 章：策略建議

第16章調查會社について,免責事項

The Pharmaceutical Packaging market was valued at USD 153.10 Billion in 2024 and is expected to reach USD 266.54 Billion by 2030 with a CAGR of 9.68%. The Global Pharmaceutical Packaging Market is experiencing rapid structural evolution, fueled by the surge in pharmaceutical manufacturing volumes, heightened emphasis on regulatory compliance, and continuous innovation in drug delivery systems. Packaging has become a strategic enabler in the pharmaceutical value chain ensuring product stability, patient safety, and regulatory transparency, while also improving logistical efficiency across increasingly complex global supply networks.

This transformation is further accelerated by the growing demand for biologics, specialty medicines, and personalized therapies, all of which require more sophisticated and often customized packaging formats. The market is set for robust and sustained growth, underpinned by advanced material science, digital traceability solutions, and the tightening of global regulatory standards all reshaping the future of pharmaceutical packaging.

Key Market Drivers

Rising Global Pharmaceutical Production

The rising global pharmaceutical production is a powerful driver fueling the growth of the Global Pharmaceutical Packaging Market, as it directly increases the demand for diverse, high-quality, and regulatory-compliant packaging solutions. As pharmaceutical manufacturing scales up across both developed and emerging markets to meet growing healthcare needs, the need for robust, efficient, and specialized packaging becomes indispensable. As pharmaceutical output increases globally, so does the volume of drugs that require packaging from tablets and capsules to injectables, powders, and liquids. Every drug unit must be securely packaged for protection, distribution, and administration. This surge in production automatically translates into a higher demand for primary, secondary, and tertiary packaging materials, ranging from blister packs and bottles to cartons, shrink wraps, and pallets.

Each year, the expiration of patents for blockbuster drugs results in substantial revenue losses for pharmaceutical companies, often amounting to billions of dollars. Between 2025 and 2030, the industry is bracing for one of the most significant patent cliffs in its history, with approximately 200 high-revenue drugs expected to lose exclusivity. This wave of expirations threatens to impact an estimated USD 236 billion to USD 400 billion in global pharmaceutical revenues, intensifying competitive pressures and accelerating the shift toward generics and biosimilars. The expiration of patents for numerous blockbuster drugs has led to a sharp rise in generic drug production, especially in cost-sensitive markets such as India, Brazil, and Southeast Asia. Generic drug manufacturers produce in high volumes and operate on tight margins, creating a massive requirement for cost-effective, scalable, and regulatory-approved packaging solutions. This has resulted in significant packaging consumption globally, especially in the primary packaging category. With the pharmaceutical industry expanding internationally, especially through outsourcing of manufacturing to Contract Manufacturing Organizations (CMOs), production is now distributed across regions. This globalization requires uniform, compliant, and tamper-proof packaging that can ensure drug quality throughout long supply chains. As a result, packaging is no longer a local activity it has become a critical global function that must support international standards and logistics.

Cipla has developed and commercialized over 200 generic formulations and complex active pharmaceutical ingredients (APIs), which are currently exported to 62 countries across global markets. The increase in pharmaceutical production is not limited to traditional solid dosage forms. There is growing production of liquid drugs, injectables, biologics, biosimilars, and topical formulations, each requiring unique and often sophisticated packaging solutions. The diversification in drug forms has expanded the demand for customized packaging systems, such as glass vials, pre-filled syringes, temperature-controlled packaging, and child-resistant containers.

The pace of new pharmaceutical product introductions has accelerated notably in recent years. Between 2010 and 2019, the number of prescription drug launches rose by 60%, reflecting a sharp uptick in innovation and regulatory approvals. In 2023, the trend continued, with oncology accounting for 38% of all new product launches underscoring the industry's strategic focus on high-value, specialty therapeutics. Pharmaceutical companies are accelerating their drug development pipelines to respond to global health needs, such as chronic diseases, infectious diseases, and pandemics. The increase in new product launches including both prescription drugs and OTC products requires tailored packaging designs to ensure proper delivery, branding, patient adherence, and regulatory compliance. Each new product introduction amplifies the demand for specialized packaging formats and materials

Key Market Challenges

Stringent and Evolving Regulatory Requirements

Pharmaceutical packaging must meet strict international, national, and regional regulations to ensure drug safety, efficacy, and traceability. Regulatory bodies such as the U.S. FDA, European Medicines Agency (EMA), and World Health Organization (WHO) impose comprehensive rules regarding material selection, labeling, tamper-evidence, child resistance, and serialization.

Adhering to these stringent standards requires significant investment in testing, quality control, and certification. Small and mid-sized packaging companies often struggle to keep up with compliance requirements. New entrants face difficulties entering regulated markets due to complex approval processes and the need to demonstrate full regulatory compliance. Global pharmaceutical companies must tailor packaging for each market due to differing local regulations. This increases production complexity, time-to-market, and costs.

While regulations ensure safety, they also add layers of cost and complexity, which may slow down innovation, deter investment, and reduce the ability of manufacturers to scale globally.

Key Market Trends

Integration of Smart and Connected Packaging Solutions

The adoption of smart packaging technologies which combine traditional packaging with digital features like RFID tags, QR codes, NFC (Near Field Communication), time-temperature indicators, and even sensors is transforming pharmaceutical packaging into an active part of the drug delivery and monitoring process.

As counterfeiting becomes a growing concern in global pharmaceutical supply chains, smart packaging enables real-time authentication and track-and-trace systems that help verify the origin, condition, and authenticity of medicines. Packaging embedded with digital tools can provide reminders, usage instructions, and refill alerts through smartphones, significantly improving medication adherence especially for chronic disease and elderly patients. Connected packaging offers manufacturers and healthcare providers access to usage data, environmental exposure history (e.g., temperature, humidity), and supply chain movement, which can optimize logistics and pharmacovigilance efforts.

Smart packaging is evolving from a luxury feature to a competitive differentiator, particularly in high-value therapies such as biologics and specialty drugs. It opens new revenue streams, encourages brand loyalty, and aligns with the industry's push toward digitally enabled healthcare.

Key Market Players

• Amcor plc
• Becton, Dickinson, and Company
• AptarGroup, Inc
• Drug Plastics & Glass Co., Inc
• Gerresheimer AG
• Schott AG
• O-I Glass, Inc.
• West Pharmaceutical Services, Inc
• WestRock Company
• SGD Pharma

Report Scope:

In this report, the Global Pharmaceutical Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Packaging Market, By Material:

• Plastics & Polymers
• Paper & Paperboard
• Glass
• Aluminium Foil
• Others

Pharmaceutical Packaging Market, By Product:

• Primary
• Secondary
• Tertiary

Pharmaceutical Packaging Market, By Drug Delivery:

• Oral Drugs
• Injectables
• Topical
• Ocular/ Ophthalmic
• Nasal
• Pulmonary
• Transdermal
• IV Drugs
• Others

Pharmaceutical Packaging Market, By End Use:

• Pharma Manufacturing
• Contract Packaging
• Retail Pharmacy
• Institutional Pharmacy

Pharmaceutical Packaging Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Packaging Market.

Available Customizations:

Global Pharmaceutical Packaging market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID 19 on Pharmaceutical Packaging Market

5. Pharmaceutical Packaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminium Foil, Others)
  • 5.2.2. By Product (Primary, Secondary, Tertiary)
  • 5.2.3. By Drug Delivery (Oral Drugs, Injectables, Topical, Ocular/ Ophthalmic, Nasal, Pulmonary, Transdermal, IV Drugs, Others)
  • 5.2.4. By End Use (Pharma Manufacturing, Contract Packaging, Retail Pharmacy, Institutional Pharmacy)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Pharmaceutical Packaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material
  • 6.2.2. By Product
  • 6.2.3. By Drug Delivery
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Packaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Drug Delivery
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada Pharmaceutical Packaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Drug Delivery
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico Pharmaceutical Packaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Drug Delivery
      • 6.3.3.2.4. By End Use

7. Europe Pharmaceutical Packaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material
  • 7.2.2. By Product
  • 7.2.3. By Drug Delivery
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmaceutical Packaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Drug Delivery
      • 7.3.1.2.4. By End Use
  • 7.3.2. United Kingdom Pharmaceutical Packaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Drug Delivery
      • 7.3.2.2.4. By End Use
  • 7.3.3. Italy Pharmaceutical Packaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Drug Delivery
      • 7.3.3.2.4. By End Use
  • 7.3.4. France Pharmaceutical Packaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Material
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Drug Delivery
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Pharmaceutical Packaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Material
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Drug Delivery
      • 7.3.5.2.4. By End Use

8. Asia-Pacific Pharmaceutical Packaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material
  • 8.2.2. By Product
  • 8.2.3. By Drug Delivery
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Packaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Drug Delivery
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Pharmaceutical Packaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Drug Delivery
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan Pharmaceutical Packaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Drug Delivery
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea Pharmaceutical Packaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Material
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Drug Delivery
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Pharmaceutical Packaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Material
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Drug Delivery
      • 8.3.5.2.4. By End Use

9. South America Pharmaceutical Packaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material
  • 9.2.2. By Product
  • 9.2.3. By Drug Delivery
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Packaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Drug Delivery
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina Pharmaceutical Packaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Drug Delivery
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia Pharmaceutical Packaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Drug Delivery
      • 9.3.3.2.4. By End Use

10. Middle East and Africa Pharmaceutical Packaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Material
  • 10.2.2. By Product
  • 10.2.3. By Drug Delivery
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Packaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Material
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Drug Delivery
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia Pharmaceutical Packaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Material
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Drug Delivery
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE Pharmaceutical Packaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Material
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Drug Delivery
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Pharmaceutical Packaging Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Amcor plc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Becton, Dickinson, and Company
• 14.3. AptarGroup, Inc
• 14.4. Drug Plastics & Glass Co., Inc
• 14.5. Gerresheimer AG
• 14.6. Schott AG
• 14.7. O-I Glass, Inc.
• 14.8. West Pharmaceutical Services, Inc
• 14.9. WestRock Company
• 14.10.SGD Pharma

15. Strategic Recommendations

16. About Us & Disclaimer